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Methods. A cross-sectional study at a university-based HIV clinic evaluated prevalence and correlates of ED medication prescription among established male HIV+ patients in 2011-12. Patients were included if ≥19 years old, in care for >1 year, with at least 2 visits ≥90 days apart within the last year. Multivariable (MV) log-binomial regression models were used to evaluate associations ( prevalence ratio, PR with 95% confidence interval, CI) of patient characteristics with ED medication prescription.
Results. Of 1,170 HIV+ men, 269 (23%) were prescribed ED medication (mean age 50, 27% heterosexual and 73% MSM, 41% African American). Similar prevalence of ED medication prescription was observed for MSM (22%) and heterosexual men (26%). Among men on ED medications who took a survey regarding current sexual risk behavior, 181/234 (77%) reported multiple partners, 57/144 (40%) sex without condom use and 73/230 (32%) sex after alcohol/drug use. In MV analysis, age ≥ 50 years (PR = 1.5; 95% Cl 1.2-1.8), multiple sexual partners (1.9; 1.4-2.5), sex after alcohol/drugs (1.3; 1.0-1.7), and prior history of STI (1.4; 1.1-1.7) were significantly associated with ED medication prescription, while sexual orientation, race, insurance, substance use, and viral load were not. Annual protocol-driven syphilis testing was done in 253/269 (94%) of men on ED medication, with 9 (4%) positive for new infection. In contrast providers performed less annual testing for Neisseria gonorrhoeae (GC) and Chlamydia trachomatis (CT): 83/269 (31%), of whom 3 were GC positive and 1 CT positive. Among MSM on ED medication (n = 196), GC/CT testing was done in 55 (28%), of whom 54 received urogenital testing and 14 rectal testing.
Conclusion. In this cross-sectional study, ED medication prescription was significantly associated with sexual risk behavior in HIV+ men. Incidence of syphilis among men on ED medications was high. Screening for GC and CT needs to be increased, particularly rectal screening among MSM.
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